Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Westermann

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Cell Death and Differentiation|March 9, 2018
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatmentJing Shen, Sara Najafi, Sina Stäble, et al.
Cell Death & Disease|August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomasSonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
Nucleic Acids Research|April 30, 2013
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastomaMarco Lodrini, Ina Oehme, Christina Schroeder, et al.
Life Science Alliance|March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastomaElena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
British Journal of Cancer|June 28, 2024
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumoursTill Seiboldt, Constantia Zeiser, Duy Nguyen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2023
Asymmetric Adrenals: Sexual Dimorphism of Adrenal TumorsNicole Bechmann, Mats Leif Moskopp, Georgiana Constantinescu, et al.
Oncotarget|December 18, 2015
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaDavid J Duffy, Aleksandar Krstic, Melinda Halasz, et al.
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signatureKatleen De Preter, Joëlle Vermeulen, Benedikt Brors, et al.
Scientific Reports|February 4, 2015
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screenMartin Michaelis, Bishr Agha, Florian Rothweiler, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Cell Death and Differentiation|March 9, 2018
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatmentJing Shen, Sara Najafi, Sina Stäble, et al.
Cell Death & Disease|August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomasSonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
Nucleic Acids Research|April 30, 2013
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastomaMarco Lodrini, Ina Oehme, Christina Schroeder, et al.
Life Science Alliance|March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastomaElena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
British Journal of Cancer|June 28, 2024
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumoursTill Seiboldt, Constantia Zeiser, Duy Nguyen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2023
Asymmetric Adrenals: Sexual Dimorphism of Adrenal TumorsNicole Bechmann, Mats Leif Moskopp, Georgiana Constantinescu, et al.
Oncotarget|December 18, 2015
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaDavid J Duffy, Aleksandar Krstic, Melinda Halasz, et al.
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signatureKatleen De Preter, Joëlle Vermeulen, Benedikt Brors, et al.
Scientific Reports|February 4, 2015
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screenMartin Michaelis, Bishr Agha, Florian Rothweiler, et al.
Pageof 14